Immunometabolism and potential targets in severe COVID-19 peripheral immune responses
Shanshan Wang,
Xian Zeng,
Yali Wang,
Yuzong Chen,
Chaoxin Wang,
Dongzhi Zhuoma,
Fengying Zhang,
Yufen Zhao
Affiliations
Shanshan Wang
Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China
Xian Zeng
Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai 201203, China
Yali Wang
Bioinformatics and Drug Design Group, Department of Pharmacy, National University of Singapore, 117543, Singapore
Yuzong Chen
Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China; Bioinformatics and Drug Design Group, Department of Pharmacy, National University of Singapore, 117543, Singapore
Chaoxin Wang
Department of Computer Science, Kansas State University, Manhatten KS 66506, USA
Dongzhi Zhuoma
Medical College, Tibet University, 36 Jiangsu Road, Lhasa 850011 China
Fengying Zhang
Key Lab of Agricultural Products Processing and Quality Control of Nanchang City, Jiangxi Agricultural University, Nanchang 330045, China; Corresponding author.
Yufen Zhao
Qian Xuesen Collaborative Research Center of Astrochemistry and Space Life Sciences, Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China; Corresponding author.
